Disclosed is a compound of formula (I) (i.e., N-(4-((4-(3-(3-tert-Butyl-1-p-tolyl-1H-pyrazol-5-yl)ureido)naphthalene-1-yloxy)methyl)pyridine-2-yl)-2-methoxyacetamide) or a pharmaceutically acceptable salt or solvate thereof, including all tautomers thereof. Further disclosed is a pharmaceutical composition comprising said compound, a process for the preparation of said compound, and the use of said compound in the treatment or prevention of conditions such as chronic bronchitis, emphysema, asthma, rheumatoid arthritis, cancer, etc.
